Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
Sequenom, Inc. announced it is terminating its exchange offer to acquire all of the outstanding shares of common stock of EXACT Sciences Corporation without accepting for exchange or exchanging any shares of EXACT Sciences common stock. Sequenom had previously announced that it would terminate the exchange offer if EXACT Sciences entered into any out-licensing agreement, collaboration or financial restructuring. Sequenom continues to be committed to building its oncology diagnostic franchise.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Anthony_Todd_Thomson
Category:EC_5.3.3
Terminalia_schimperiana
Technology to create SMART bandage tool to help monitor, heal wounds
Understanding addiction in the adolescent mind

Stanford scientists solve mystery of arsenic release into groundwater
Cerastes_(genus)
Category:EC_3.1.26
Nose_cancer_in_cats_and_dogs
105 additional genetic errors that cause cystic fibrosis - Discovery increases diagnostic certainty and opportunity for individualized drug therapy
